Forgot your password?
The trial has been evaluating the drug in patients with darker skin tones
The long-term study has been evaluating the drug in over 1,900 patients with moderate-to-severe cases
The partners will aim to advance cutaneous drug delivery for the rare genetic skin disorders
The drug is approved for plaque psoriasis, hidradenitis suppurativa and other inflammatory conditions
Up to 90% of patients primary biliary cholangitis experience pruritus
The gene therapy demonstrated significant wound healing and pain reduction in RDEB
Over 300,000 chronic spontaneous urticaria patients in the US are inadequately controlled by antihistamines
The agreement will focus on enhancing skin disease understanding
The phase 2 SCOPE study will evaluate the needle-free injection in patients with advanced unresectable cases of the disease
Researchers looked a naturally occurring peptide that regulates inflammation